KRISTIN KREMERS: Open Payments
NPI 1760741482 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 18 payments from 10 companies in 2025. Trend: 2023 $121 · 2024 $229 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| CSL Behring | 2 | $47 |
| Integra LifeSciences Corporation | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Ambu Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| BioCryst US Sales Co., LLC | 1 | $17 |
| Grifols USA, LLC | 1 | $15 |
Products named: DUPIXENT, Haegarda, ACCLARENT AERA, TEZSPIRE, NUCALA, CUVITRU, AIRSUPRA, ORLADEYO.
Industry payments across ND — which companies pay providers there.
